Target intelligence / Profile preview

Microbial cell envelopes and intracellular macromolecules

Molecular classification
Other
01

Overview

Microbial cell envelopes and intracellular macromolecules represent the collective structural and functional components of pathogenic microorganisms that serve as the primary targets for antimicrobial therapy. The cell envelope, consisting of the cell wall (e.g., peptidoglycan in bacteria) and the cytoplasmic membrane, provides essential protection against osmotic pressure and environmental stress [1]. Intracellular macromolecules include the microbial genome (DNA), transcription machinery (RNA), and the translation apparatus (ribosomes), which are vital for the survival, growth, and replication of the pathogen [2]. Antimicrobial drugs are designed to exploit the biochemical differences between these microbial structures and human cells to achieve selective toxicity. For instance, beta-lactams and glycopeptides target cell wall assembly, while aminoglycosides and tetracyclines bind to microbial ribosomes to halt protein synthesis [3]. Understanding these targets is fundamental to the development of treatments for a wide range of bacterial, fungal, and parasitic infections. [1] Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010;2(5):a000414. [2] Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010;8(6):423-435. [3] Walsh C. Antibiotics: Actions, Origins, Resistance. Washington (DC): ASM Press; 2003.

Other names
Bacterial cell wall and cytoplasmic componentsMicrobial structural and functional macromolecules
02

Mechanism of action

Inhibition of cell wall synthesis, disruption of cell membrane integrity, inhibition of protein synthesis, and inhibition of nucleic acid synthesis

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Antimicrobial resistance (AMR)Off-target toxicity (e.g., nephrotoxicity, ototoxicity)Disruption of the human microbiome
06

Interacting drugs

Penicillin G

4 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Minimum Bactericidal Concentration (MBC)Pathogen clearance rateC-reactive protein (CRP)Procalcitonin

Beyond the preview

Go deeper on Microbial cell envelopes and intracellular macromolecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell envelopes and intracellular macromolecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call